- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
John Theurer Cancer Center, Hackensack University Medical Center | Strategic Alliance Partners
ABOUT HACKENSACK UNIVERSITY MEDICAL CENTER
Hackensack University Medical Center, a 803-bed nonprofit teaching and research hospital, was Bergen County’s first hospital founded in 1888. It was also the first hospital in New Jersey and second in the nation to become a Magnet®-recognized hospital for nursing excellence, receiving its sixth consecutive designation from the American Nurses Credentialing Center. The academic flagship of the Hackensack Meridian Health network, Hackensack University Medical Center is Nationally-Ranked by U.S. News & World Report 2022-2023 in four specialties, more than any other hospital in New Jersey. The hospital is home to the state's only nationally-ranked Urology and Neurology & Neurosurgery programs, as well as the best Cardiology & Heart Surgery program. It also offers patients nationally-ranked Orthopedic care and one of the state’s premier Cancer Centers (John Theurer Cancer Center at Hackensack University Medical Center). Hackensack University Medical Center also ranked as High-Performing in conditions such as Acute Kidney Failure, Heart Attack (AMI), Heart Failure, Pneumonia, chronic obstructive pulmonary disease (COPD), Diabetes and Stroke. As well as High Performing in procedures like Aortic Valve Surgery, Heart Bypass Surgery (CABG), Colon Cancer Surgery, Lung Cancer Surgery, Prostate Cancer Surgery, Hip Replacement and Knee Replacement. Named to Newsweek’s World’s Best Hospitals 2023 list, Hackensack University Medical Center is also the recipient of the 2023 Patient Safety Excellence Award™ by Healthgrades as well as an “A” Hospital Safety Grade from The Leapfrog Group. This award-winning care is provided on a campus that is home to facilities such as the Heart & Vascular Hospital; and the Sarkis and Siran Gabrellian Women’s and Children’s Pavilion, which houses the Donna A. Sanzari Women’s Hospital and the Joseph M. Sanzari Children’s Hospital, ranked #1 in the state and top 20 in the Mid-Atlantic Region in the U.S. News & World Report’s 2022-23 Best Children’s Hospital Report. Additionally, the children’s nephrology program ranks in the top 50 in the United States. Hackensack University Medical Center is also home to the Deirdre Imus Environmental Health Center and is listed on the Green Guide’s list of Top 10 Green Hospitals in the U.S. Our comprehensive clinical research portfolio includes studies focused on precision medicine, translational medicine, immunotherapy, cell therapy, and vaccine development. The hospital has embarked on the largest healthcare expansion project ever approved by the state: Construction of the Helena Theurer Pavilion, a 530,000-sq.-ft., nine-story building, which began in 2019. A $714.2 million endeavor, the pavilion is one the largest healthcare capital projects in New Jersey and will house 24 state-of-the-art operating rooms with intraoperative MRI capability, 50 ICU beds, and 175 medical/surgical beds including a 50 room Musculoskeletal Institute.
Latest from John Theurer Cancer Center, Hackensack University Medical Center
Hackensack Meridian Health Celebrates Opening of the Institute for Multiple Myeloma
August 17, 2018
Article
Hackensack Meridian Health, New Jersey’s largest and most comprehensive healthcare network, is proud to announce the opening of the Institute for Multiple Myeloma which will support groundbreaking research to enhance treatment of this rare cancer.
Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma
August 08, 2018
Article
Noa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.
Dr. Goy on the Combination of Biological Therapies in Relapsed MCL
August 03, 2018
Video
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the combination of biological therapies in the treatment of patients with relapsed mantle cell lymphoma (MCL).
Dr. Goy on the Evolution of Treatment in Mantle Cell Lymphoma
July 26, 2018
Video
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the evolution of treatment in mantle cell lymphoma (MCL).
Goy Discusses Latest Lymphoma Data
July 24, 2018
Article
Andre Goy, MD, discusses some of the most important lymphoma data presented at the 2018 ASCO Annual Meeting and potential future directions for treatment.
Dr. Biran Discusses Treatment Discontinuation in Myeloma
July 13, 2018
Video
Noa Biran, MD, physician, Multiple Myeloma Division, John Theurer Cancer Center, discusses treatment discontinuation in multiple myeloma.
Dr. Goy Discusses the Evolution of Treatment for MCL
May 09, 2018
Video
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the evolving treatment landscape of mantle cell lymphoma.
Dr. Skarbnik Discusses the Changing Landscape of CLL
May 07, 2018
Video
Alan Skarbnik, MD, staff physician, Department of Bone Marrow Transplantation and Department of Lymphoma, John Theurer Cancer Center, discusses the changing treatment landscape of chronic lymphocytic leukemia.
Dr. Leslie Discusses Advancements in Mantle Cell Lymphoma
April 28, 2018
Video
Lori A. Leslie, MD, lymphoma attending, John Theurer Cancer Center, discusses advancements in mantle cell lymphoma.
Expert Reviews CLL Advances Presented at ASH
April 05, 2018
Article
Alan Skarbnik, MD, shares his insight on the latest updates in chronic lymphocytic leukemia presented at the 2017 ASH Annual Meeting.
Dr. Goy on the Importance of MRD Status in Patients With MCL
April 04, 2018
Video
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the importance of achieving minimal residual disease (MRD) negativity in mantle cell lymphoma (MCL).
Dr. Goldberg on FDA-Approved Agents for Patients With AML
April 02, 2018
Video
Stuart L. Goldberg, MD, hematologist, John Theurer Cancer Center, discusses the use of 4 FDA-approved agents for patients with acute myeloid leukemia (AML) with varying genetic alterations.
Dr. Biran Discusses Doublets Versus Triplets in Myeloma
March 30, 2018
Video
Noa Biran, MD, physician, Multiple Myeloma Division, John Theurer Cancer Center, discusses doublets versus triplets in the treatment of patients with multiple myeloma.
Dr. Skarbnik on the Role of Chemotherapy in CLL
March 30, 2018
Video
Alan Skarbnik, MD, staff physician, Department of Bone Marrow Transplantation and Department of Lymphoma, John Theurer Cancer Center, discusses the use of chemotherapy in patients with chronic lymphocytic leukemia (CLL).
Dr. Leslie Discusses 2017 ASH Annual Meeting Updates
March 27, 2018
Video
Lori A. Leslie, MD, lymphoma attending, John Theurer Cancer Center, discusses trial updates for patients with follicular lymphoma in the maintenance setting, which were presented at the 2017 ASH Annual Meeting.
MDAdvantage Announces 2018 Recipients of Prestigious Excellence in Medicine Awards
March 09, 2018
Article
MDAdvantage Insurance Company, a leading provider of medical professional liability insurance, today announced the 2018 EJI Excellence in Medicine award recipients. Honoring New Jersey healthcare providers, the Excellence in Medicine Awards are among the highest honors presented to New Jersey's medical community.
John Theurer Cancer Center Presents 15th Annual Northern NJ Breast Cancer Conference
March 09, 2018
Article
2017 San Antonio Breast Cancer Symposium Review - February 23
John Theurer Cancer Center First NJ Site Certified to offer CAR-T Cell Cancer Therapy
March 09, 2018
Article
Breakthrough gene therapy for B-cell lymphoma now available at Hackensack University Medical Center.
Andrew L. Pecora, M.D. receives the 2018
March 09, 2018
Article
Chief innovations officer at Hackensack Meridian Health Recognized for Vision, Innovation and Leadership.
April Camiling Honored with Excellence in Nursing Award from Modern Healthcare
March 09, 2018
Article
Hackensack Meridian Health Hackensack University Medical Center is proud to announce that April Camiling, MSN, RN, AOCNS, BMTCN, oncology nurse specialist in Blood and Marrow Transplant (BMT) at John Theurer Cancer Center - Hackensack University Medical Center, has been recognized by Modern Healthcare as a Rising Star recipient in the 2018 Excellence in Nursing Award program.